Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$21.91 USD
+0.85 (4.04%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $21.88 -0.03 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RIGL 21.91 +0.85(4.04%)
Will RIGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RIGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RIGL
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
Why Rigel (RIGL) Could Beat Earnings Estimates Again
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect?
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
Other News for RIGL
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and ...
RIGL Crosses Above Key Moving Average Level
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | ...
RIGL Makes Bullish Cross Above Critical Moving Average
Nuvation Bio: Judgement Day Grows Closer